University of Maryland Institute to Apply AI to Healthcare

University of Maryland Health Computing’s newly announced Health Computing Institute seeks to use artificial intelligence (AI) and computer advances to create a health learning system that evaluates de-identified and secure digital medical health information to diagnose, prevent, and treat patient diseases. will be throughout the state of Maryland.

The institute is the result of a partnership between the University of Maryland, Baltimore (UMB) and the University of Maryland, College Park (UMCP), University of Maryland Medical System (UMMS) and Montgomery County, MD.

University of Maryland System Chancellor Jay Perman, MD, said in a statement that UMB’s triad of biomedicine in the professional schools of health sciences; College Park’s cutting-edge expertise in artificial intelligence, virtual reality, and machine learning; Serving more than 5 million patients connected through electronic health records, UMMS demonstrates that there is a great deal to be done in healthcare innovation.

The institute “brings together the advanced computing of the University of Maryland and the deep human health expertise of UMB and UMMS,” Perman said. “First – advanced computing – second – using our health is a wonderful thing.”

Also Read :  New Developments, ChatGPT 4, and Whatnot!

The institute will use machine learning to study emerging diseases and help create precise patient care to stop disease progression. For example, poorly controlled diabetes, high blood pressure, risk of opioid overdose, and early kidney disease can be identified through changes in laboratory tests in the outpatient setting, and targeted interventions can prevent disease progression.

UMMS President and CEO Mohan Sunta, MD, MBA, noted his pride in working with the system’s 12 affiliated hospitals as part of a university-based health system. “While we provide care today, we also face the responsibility of educating the healthcare workers of tomorrow,” he said in a statement. “We do this through partnerships, so when I look around today, I’m really excited about the partners who are sitting together to make this announcement,” he continued.

Also Read :  Node.js vs Python: Which One Should You Use for Web Apps?

The institute engages FDA and NIH researchers, UMB and UMCP faculty, medical bioinformatics education programs and students, and industry partners in North Bethesda, and provides expanded clinical informatics computing “dry” labs, virtual conference rooms, and classrooms. hoping to stimulate the scientific ecosystem. .

The institute is expected to open in leased space in early 2023, with lab and office space planned for completion in 2028 at the North Bethesda metro location. The first $25 million in funding was provided by the University of Maryland’s Strategic Partnerships: Empowering Public Power (MPpower) . The Montgomery County government will provide an additional $40 million to develop the North Bethesda site.

In addition to the new institute, the University of Maryland System of Medicine announced last year that it would partner with health technology company Vibrent Health to create the Maryland All-Specialty Health Initiative, a statewide digital platform to study how genes and other factors influence health. .

Also Read :  'The Princess Diaries 3' Is In The Works, And The Internet Is Freaking Out

Led by researchers at the University of Maryland School of Medicine (UMSOM), the all-Maryland mission is to find better ways to personalize health care. The goal is to allow individuals to receive treatment tailored to their specific health needs.

This data-driven study will target up to 250,000 volunteers across Maryland to better understand and identify the health needs of Marylanders by region and community. Particular attention will be given to underserved populations that have greater health disparities, greater morbidity and shorter life expectancy. A wide range of health data sources, including major efforts to collect genetic information, will help researchers better understand variation in the human genome and its relationship to disease and treatment.


Leave a Reply

Your email address will not be published.

Related Articles

Back to top button